Thibault Boutherin
Stock Analyst at Morgan Stanley
(3.90)
# 1,905
Out of 5,144 analysts
147
Total ratings
64%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: SAN Sanofi | Reiterated: Hold | €82.00 → €86.00 | €86.56 | -0.65% | 2 | Nov 3, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Buy | CHF 135.00 | CHF 133.28 | +1.29% | 15 | Oct 28, 2026 | |
| NVS Novartis AG | Reiterated: Buy | $156 → $163 | $159.13 | +2.43% | 5 | Oct 28, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 650.00 | CHF 663.00 | -1.96% | 11 | Oct 14, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Sell | CHF 50.00 → CHF 60.00 | CHF 83.00 | -27.71% | 5 | Oct 6, 2026 | |
| NVO Novo Nordisk | Downgraded: Sell | $40 | $40.70 | -1.72% | 6 | Sep 11, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Hold | CHF 155.00 → CHF 160.00 | CHF 187.15 | -14.51% | 9 | Apr 27, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €40.00 → €53.00 | €56.14 | -5.59% | 5 | Mar 11, 2026 | |
| BME: GRF Grifols, S.A. | Downgraded: Hold | €12.00 → €11.00 | €11.53 | -4.60% | 7 | Mar 10, 2026 | |
| ALVO Alvotech | Reiterated: Buy | $14 → $10 | $4.37 | +128.83% | 4 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €130.00 → €135.00 | €150.75 | -10.45% | 5 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $36 | $29.04 | +23.97% | 10 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €300.00 | €291.50 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €250.00 | €224.20 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 2,100p → 2,400p | 1,675p | n/a | 15 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €12.00 | €2.75 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 | $1.48 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €120.00 | €164.10 | n/a | 18 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $38 | $99.14 | n/a | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | CHF 4.00 → CHF 1.00 | CHF 3.97 | n/a | 11 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $8.63 | n/a | 4 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €11.50 → €11.00 | €10.50 | n/a | 5 | Nov 13, 2023 |
Sanofi
Nov 3, 2026
Reiterated: Hold
Price Target: €82.00 → €86.00
Current: €86.56
Upside: -0.65%
Novartis AG
Oct 28, 2026
Reiterated: Buy
Price Target: CHF 135.00
Current: CHF 133.28
Upside: +1.29%
Novartis AG
Oct 28, 2026
Reiterated: Buy
Price Target: $156 → $163
Current: $159.13
Upside: +2.43%
Lonza Group AG
Oct 14, 2026
Reiterated: Buy
Price Target: CHF 650.00
Current: CHF 663.00
Upside: -1.96%
Sandoz Group AG
Oct 6, 2026
Reiterated: Sell
Price Target: CHF 50.00 → CHF 60.00
Current: CHF 83.00
Upside: -27.71%
Novo Nordisk
Sep 11, 2026
Downgraded: Sell
Price Target: $40
Current: $40.70
Upside: -1.72%
Galderma Group AG
Apr 27, 2026
Reiterated: Hold
Price Target: CHF 155.00 → CHF 160.00
Current: CHF 187.15
Upside: -14.51%
Bayer Aktiengesellschaft
Mar 11, 2026
Reiterated: Buy
Price Target: €40.00 → €53.00
Current: €56.14
Upside: -5.59%
Grifols, S.A.
Mar 10, 2026
Downgraded: Hold
Price Target: €12.00 → €11.00
Current: €11.53
Upside: -4.60%
Alvotech
Dec 3, 2025
Reiterated: Buy
Price Target: $14 → $10
Current: $4.37
Upside: +128.83%
Dec 3, 2025
Reiterated: Hold
Price Target: €130.00 → €135.00
Current: €150.75
Upside: -10.45%
Dec 3, 2025
Reiterated: Buy
Price Target: $25 → $36
Current: $29.04
Upside: +23.97%
Apr 22, 2025
Reiterated: Buy
Price Target: €300.00
Current: €291.50
Upside: n/a
Apr 22, 2025
Reiterated: Buy
Price Target: €250.00
Current: €224.20
Upside: n/a
Feb 12, 2025
Reiterated: Hold
Price Target: 2,100p → 2,400p
Current: 1,675p
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: €12.00
Current: €2.75
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: $13
Current: $1.48
Upside: n/a
May 15, 2024
Reiterated: Hold
Price Target: €120.00
Current: €164.10
Upside: n/a
May 8, 2024
Reiterated: Hold
Price Target: $36 → $38
Current: $99.14
Upside: n/a
Apr 3, 2024
Reiterated: Sell
Price Target: CHF 4.00 → CHF 1.00
Current: CHF 3.97
Upside: n/a
Dec 29, 2023
Reiterated: Hold
Price Target: $16
Current: $8.63
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: €11.50 → €11.00
Current: €10.50
Upside: n/a